v2.3.0.15
Consolidated Balance Sheets (USD $)
In Thousands
Sep. 30, 2011
Sep. 24, 2010
ASSETS  
Cash and cash equivalents$ 551,512$ 545,861
Short-term investments391,281302,269
Accounts receivable, net of allowance of $2,040 at September 24, 2010 and $2,466 at September 30, 201161,81554,257
Inventories26,24428,338
Deferred taxes90,869102,758
Prepaid expenses and other current assets36,87726,930
Total current assets1,158,5981,060,413
Long-term investments272,797[1]190,837[1]
Property, plant and equipment, net117,10794,097
Intangible assets, net51,57367,019
Goodwill263,260264,580
Deferred taxes14,77919,948
Other non-current assets6,27314,878
Total assets1,884,3871,711,772
LIABILITIES AND STOCKHOLDERS' EQUITY  
Accounts payable10,8873,606
Accrued liabilities117,035144,608
Income taxes payable4,7627,895
Deferred revenue26,7019,647
Total current liabilities159,385165,756
Long-term deferred revenue15,52612,775
Deferred taxes67111,547
Other non-current liabilities23,45527,015
Total liabilities199,037217,093
Stockholders' equity:  
Additional paid-in capital210,681329,902
Retained earnings1,445,1891,135,922
Accumulated other comprehensive income7,5337,801
Total stockholders' equity-Dolby Laboratories, Inc.1,663,5131,473,737
Controlling interest21,83720,942
Total stockholders' equity1,685,3501,494,679
Total liabilities and stockholders' equity1,884,3871,711,772
Class A Common Stock [Member]
  
Stockholders' equity:  
Common stock5253
Class B Common Stock [Member]
  
Stockholders' equity:  
Common stock$ 58$ 59
[1]Our long-term investments have maturities that range from one to three years.